Skip to content

Study on Hair Serum & Vitamin Gummies for Reducing Hair Fall and Growth Improvement.

A randomized, controlled, parallel-arm, open-label clinical trial to evaluate the safety and efficacy of Hair Serum alone or in combination with Hair vitamin gummies in reducing hair fall and improving hair growth in adult male and female participants. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084228
Enrollment
60
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention1: Hair serum: Apply 1ml of the serum directly to the entire scalp and massage for two minutes. Use it twice daily: once in the morning and again at night before bed, for a duration of 3 m

Sponsors

Mosaic Wellness Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male/ Female participants in general good health; 2. Participants in the age group 18-40 years (both ages inclusive). 3. Participants falling under Grade I-1 to II-1 or frontal of savins pictorial grading of female pattern hair loss or under Grade 2 to 4A of hair loss severity grade evaluated as per Norwood scale. 4. Participant with at least one of the following complaints Dry, damaged hair Brittle and thin hair Hair loss evident while combing or after washing Perceived reduced hair density Scalp-related complaints like itching, dandruff or irritation. 5. Willingness to maintain the same hair style, approximate length, and hair color throughout the study 6. Able to read, understand, and provide written (signed) informed before study starts. 7. Participants must be willing and able to comply study regimen and requirements in a timely manner.

Exclusion criteria

Exclusion criteria: 1. Participants who are undergoing hair growth treatment within 3 months before screening for the study. 2. Participants having any active scalp disease which may interfere with the study. 3. Prior use of scalp hair growth treatment (e.g. finasteride, minoxidil) within 6 months. 4. Participants on treatment for active acne. 5. Participants with a history or active phase of malignancy and chemotherapy. 6. Participants who have a history of alcoholism and/ or psychiatric disorders including trichotillomania. 7. Participants who take pharmaceutical products which cause hirsutism. 8. Participants on oral hair growth medications which will compromise the study. 9. Chronic illness which may influence the study 10. Participants participating in another similar cosmetic or therapeutic trial within the last two weeks. 11. Pregnant or lactating mothers. 12. Participant willing to continue his current regimen of vitamins, nutraceutical, herbal, or ayurvedic supplements for the duration of the study for hair health. 13. Participant on any medication known to cause hair loss or hair thinning (e.g. Isotretinoin). 14. Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness. 15. Known hypersensitivity to investigational product or its excipients. 16. Any prior hair growth procedures (e.g., hair transplant or laser). 17. Diagnosed with dermatologic conditions like eczema, fungal scalp infections, seborrheic dermatitis, recurrent herpes, pityriasis versicolor, psoriasis, pigmentary disorders (vitiligo, chloasma), chronic lupus erythematous. 18. Any condition that could, in the opinion of the investigator, preclude the participants ability to complete the study or that may confound study outcomes.

Design outcomes

Primary

MeasureTime frame
1. Change in the hair density and follicular density in the target area by Phototrichogram 2. Change in anagen to telogen ratio (A/T ratio) 3. Change in the hair growth rate in the target area by PhototrichogramTimepoint: screening, day 30, day 60 and day 90

Secondary

MeasureTime frame
1. Change in the number of terminal hairs, vellus hairs and and hair diameter in the target area by phototrichogram 2. Changes in number of hair shredded by 60 second hair comb test 3. Change in the number of shredded hairs after Modified hair wash test 4. Change in "Participant-Perceived Self-Hair Assessment Questionnaire" score 5. Change in visual analog scale (VAS) score for scalp related complaints like itching, dandruff or irritation reported by participants.Timepoint: screening, day 30, day 60 and day 90

Countries

India

Contacts

Public ContactShreyans Jain

Mosaic Wellness Pvt Ltd

darshani.m@mosaicwellness.in9677449243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026